Advances in Melanoma Treatment The incidence of melanoma has increased, but mortality
has declined with improved management. Sentinel-node sampling has reduced morbidity …

Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been
expanded to include pathways for treatment of microscopic satellitosis (added in v2. 2020) …

Despite significant progress in the development of treatment options, melanoma remains a
leading cause of death due to skin cancer. Advances in our understanding of the genetic …

The primary cause of the increase in melanoma incidence in the United States has been
suggested to be overdiagnosis. We used Surveillance, Epidemiology, and End Result …

This European Society for Medical Oncology (ESMO) Clinical Practice Guideline (CPG)
focuses on invasive cutaneous melanoma. The management of uveal melanoma and non …

Background Prognostic assessment of cutaneous melanoma relies on historical,
clinicopathological, and phenotypic risk factors according to American Joint Committee on …

Nodular melanoma (NM) is the second most common subtype of cutaneous melanoma
(CM), accounting for a substantial proportion of melanoma fatalities. We assessed reviews …

The development of multiomic profiling tools has rapidly expanded in recent years, along
with their use in profiling skin tissues in various contexts, including dermatologic diseases …

Simple Summary More than 40% of patients initially diagnosed with 'low risk'(stage I–II)
melanoma eventually develop melanoma recurrence or die as a result of melanoma. While …

Unraveling the multidimensional complexities of melanoma has required concerted efforts
by dedicated community of researchers and clinicians battling against this deadly form of …